Mumps: Immune status of adults and epidemiology as a necessary background for choice of vaccination strategy in Jordan

APMIS

Volumn 110, Issue 7-8, 2002, Pages 528-534

  Batayneh, Naji ^a   Bdour, Salwa ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Epidemiology; Immunity; Mumps; Vaccination

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MUMPS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; IMMUNE STATUS; INCIDENCE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MUMPS; MUMPS VIRUS; OUTCOMES RESEARCH; PRIORITY JOURNAL; SEASONAL VARIATION; SERODIAGNOSIS; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; JORDAN; MALE; MASS IMMUNIZATION; MEASLES-MUMPS-RUBELLA VACCINE; MIDDLE AGED; MUMPS; MUMPS VIRUS; PREVALENCE; SEASONS; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS;

EID: 0036695871     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2002.11007803.x     Document Type: Article

References (20)

1. Falk WA, Buchan K, Dow M, et al. The epidemiology of mumps in Southern Alberta, 1980-1982. Am J Epidemiol 1989;130:736-49.
2. Hersh BS, Fine PEM, Kent WK, et al. Mumps outbreak in a highly vaccinated population. J Pediatr 1991;119:187-93.
3. Leinikki P. Mumps. In: Zuckerman AJ, Banatvala JE, Pattison JR, editors. Principles and Practice of Clinical Virology. New York: John Wiley and Sons, 1994:401-14.
4. Immunization Practices Advisory Committee. Mumps prevention. MMWR 1997;38:397-400.
5. Hall R, Richards H. Hearing loss due to mumps. Arch Dis Child 1987;62:189-91.
6. Koskiniemi M, Donner M, Pettay O. Clinical appearance and outcome in mumps encephalitis in children. Acta Pediatr Scand 1983;72:603-9.
7. Westmore GA, Pickard BH, Stern H. Isolation of mumps virus from the inner ear after sudden deafness. Br Med J 1979;1:14-5.
8. Centers for Disease Control. Mumps Prevention. MMWR 1989;38:388.
9. Centers for Disease Control. Mumps: United States. MMWR 1987;36:151-5.
10. Briss PA, Fehrs LJ, Parker RA, Wright PF, Sannella EC, Hutcheson RH, Schaffner W. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine-induced immunity. J Infect Dis 1994;169:77-82.
11. Germann D, Strohle K, Eggenberger K, Steiner CE, Matter L. An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand J Infect Dis 1996;28:235-8.
12. Colville A, Pugh S. Mumps meningitis and measles, mumps, and rubella vaccine. Lancet 1992;340:786.
13. Miller E, Goldacre M, Pugh S, Colville A, Farrington P, Flower A, Nash J, MacFarlane L, Tettmar R. Risk of aseptic meningitis after measles, mumps and rubella vaccine in UK children. Lancet 1993;341:979-82.
14. Bakasun V. Mumps in the region of Rijeka, Croatia. Eur J Epidemiol 1997;13:117-9.
15. Bayas JM, Vilella A, Vidal J, Nebot X, Carbo JM, Navarro G, Prat Asenjo MA, Salleras L. Susceptibility to measles, rubella and parotitis in young adults. Med Clin (Barc) 1997;109:196-7.
16. Davidkin I, Valle M, Julkunen I. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow up. Vaccine 1995;13:1617-22.
17. Zach K, Nicoara C, Germann D, Matter L. Age-related seroprevalence of measles, mumps and rubella antibodies in 1996. Schweiz Med Wochenschr 1998;128:649-57.
18. Leland DS, Kleiman MB. Mumps virus. In: Laboratory Diagnosis of Viral Infections. USA. Marcel Dekker Inc., 1999:623-32.
19. Watson JC, Hadler SC, Dykewicz CA, Reef S, Philips L. Measles, mumps and rubella - vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps: recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998;47:1-57.
20. Cochi SL, Preblud SR, Orenstein WA. Perspectives on the relative resurgence of mumps in the United States. Am J Dis Child 1988;142:499-507.